Accelerate Diagnostics (AXDX)
NASDAQ:AXDX

Accelerate Diagnostics (AXDX) Financial Statements

291 Followers

Accelerate Diagnostics Financial Overview

Accelerate Diagnostics's market cap is currently ―. The company's EPS TTM is $-4.543; its P/E ratio is -0.28; Accelerate Diagnostics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 2.92M$ 3.03M$ 3.30M$ 2.92M$ 2.81M
Gross Profit$ 723.00K$ 633.00K$ 107.00K$ 799.00K$ 1.01M
EBIT$ -10.56M$ -13.86M$ 1.04M$ -32.58M$ -15.37M
EBITDA$ -9.71M$ -13.04M$ 1.86M$ -32.52M$ -13.81M
Net Income Common Stockholders$ -14.23M$ -34.45M$ 7.08M$ -32.73M$ -16.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 15.75M$ 13.22M$ 21.15M$ 29.28M$ 29.41M
Total Assets$ 30.72M$ 31.37M$ 39.32M$ 49.88M$ 51.00M
Total Debt$ 40.41M$ 39.22M$ 36.57M$ 36.57M$ 60.60M
Net Debt$ 24.66M$ 26.00M$ 15.42M$ 7.29M$ 31.20M
Total Liabilities$ 56.50M$ 51.25M$ 74.36M$ 88.54M$ 89.73M
Stockholders Equity$ -25.78M$ -19.89M$ -35.03M$ -38.66M$ -38.73M
Cash Flow-
Free Cash Flow$ -8.96M$ -7.87M$ 7.70M$ -10.97M$ -13.38M
Operating Cash Flow$ -8.45M$ -7.75M$ 8.46M$ -10.82M$ -13.37M
Investing Cash Flow$ -513.00K$ -110.00K$ -354.00K$ 915.00K$ 8.21M
Financing Cash Flow$ 11.44M$ 107.00K$ 3.18M$ 9.81M$ -77.00K
Currency in USD

Accelerate Diagnostics Earnings and Revenue History

Accelerate Diagnostics Debt to Assets

Accelerate Diagnostics Cash Flow

Accelerate Diagnostics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis